IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Aesica partners with Durham and Leeds universities to commercialize API manufacturing technology

4:09 AM MST | December 18, 2012 | Deepti Ramesh

Aesica Pharmaceuticals (Newcastle upon Tyne, UK), the University of Durham (Durham, UK), and the University of Leeds (Leeds, UK) were jointly awarded the METRC innovation grant to investigate and accelerate the development of processes that will improve cost efficiencies and increase manufacturing capacity at Aesica’s Cramlington, UK, site. The new partnership with the University of Durham and the University of Leeds will aim to develop new or improved routes for the manufacture of an active pharmaceutical ingredient (API), Aesica says. A detailed kinetic...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa